Pirfenidone Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200mg
Reference Brands:
Category: Respiratory Disorder
Tablet contains pirfenidone. It is used to treat idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a type of lung disorder in which tissues of the lungs become scarred and inflamed, resulting in breathing difficulties. This medicine should not be used if you have severe liver disorders, severe kidney disorders, if you are taking fluvoxamine (treats depression and obsessive compulsive disorder), or if you are allergic to any of the ingredients of this medicine. PIRFENIDONE is available in Tablets and strengths such as 200mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, PIRFENIDONE is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
PIRFENIDONE can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: This medicine is not recommended for adolescents and children under the age of 18. Avoid smoking as it may reduce the efficacy of the Pirfenex Tablet. Avoid exposure to sunlight, including sunlamps. Use sunscreen daily and cover your head, legs, and arms to reduce exposure to sunlight. Do not drink grapefruit juice while taking this medicine. Taking this medicine can cause weight loss.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Levalbuterol
Strength:
0.31 mg, 0.63 mg, 1.25 mg
Form: Inhalation solution
Reference Brands: Xopenex (USA/EU)
View DetailsUmeclidinium Bromide
Strength:
62.5 mcg
Form: dry-powder inhaler
Reference Brands: Incruse Ellipta (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers